Cargando…

Impact of Surgeon’s Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores

SIMPLE SUMMARY: For the transfer of suspicious lesions in magnetic resonance imaging (MRI) to ultrasound in prostate fusion biopsy, biopsy platforms can be distinguished by rigid or elastic image registration. This study evaluates the detection rate of these different platforms for transperineal fus...

Descripción completa

Detalles Bibliográficos
Autores principales: Görtz, Magdalena, Nyarangi-Dix, Joanne Nyaboe, Pursche, Lars, Schütz, Viktoria, Reimold, Philipp, Schwab, Constantin, Stenzinger, Albrecht, Sültmann, Holger, Duensing, Stefan, Schlemmer, Heinz-Peter, Bonekamp, David, Hohenfellner, Markus, Radtke, Jan Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870088/
https://www.ncbi.nlm.nih.gov/pubmed/35205634
http://dx.doi.org/10.3390/cancers14040886
_version_ 1784656653209042944
author Görtz, Magdalena
Nyarangi-Dix, Joanne Nyaboe
Pursche, Lars
Schütz, Viktoria
Reimold, Philipp
Schwab, Constantin
Stenzinger, Albrecht
Sültmann, Holger
Duensing, Stefan
Schlemmer, Heinz-Peter
Bonekamp, David
Hohenfellner, Markus
Radtke, Jan Philipp
author_facet Görtz, Magdalena
Nyarangi-Dix, Joanne Nyaboe
Pursche, Lars
Schütz, Viktoria
Reimold, Philipp
Schwab, Constantin
Stenzinger, Albrecht
Sültmann, Holger
Duensing, Stefan
Schlemmer, Heinz-Peter
Bonekamp, David
Hohenfellner, Markus
Radtke, Jan Philipp
author_sort Görtz, Magdalena
collection PubMed
description SIMPLE SUMMARY: For the transfer of suspicious lesions in magnetic resonance imaging (MRI) to ultrasound in prostate fusion biopsy, biopsy platforms can be distinguished by rigid or elastic image registration. This study evaluates the detection rate of these different platforms for transperineal fusion-guided prostate biopsy to detect clinically significant prostate cancer under consideration of the surgeon’s learning curve. In our cohort, rigid and elastic registration systems showed a similar prostate cancer detection rate in experienced surgeons, whereas novices seem to benefit from rigid fusion. In the total cohort, targeted fusion biopsy with a rigid registration system outperformed elastic registration target biopsy with a superior significant prostate cancer detection rate, each compared to systematic saturation biopsy. Thus, rigid target biopsy aided in reducing targeting errors that result in missing MRI-visualized significant prostate cancer. These results can provide valuable decision support in selecting a biopsy fusion platform to increase the detection rate and risk stratification of prostate cancer, especially at the beginning of the surgeon’s learning curve. ABSTRACT: Multiparametric magnetic resonance imaging (mpMRI) and MRI/ultrasound fusion-targeted prostate biopsy (FB) have excellent sensitivity in detecting significant prostate cancer (sPC). FB platforms can be distinguished by rigid (RTB) or elastic image registration (ETB). We compared RTB and ETB by analyzing sPC detection rates of both RTB and ETB at different stages of the surgeons’ learning curve. Patients undergoing RTB between 2015–2017 (n = 502) were compared to patients undergoing ETB from 2017–2019 (n = 437). SPC detection rates were compared by Chi-square-test on patient-basis. Combination of transperineal systematic biopsy and each TB served as reference and sub-analyses were performed for different grades of surgeon’s experience. In the RTB subgroup, 233 men (46%) had sPC, compared to 201 (46%) in the ETB subgroup. RTB alone detected 94% of men with sPC and ETB 87% (p = 0.02). However, for at least intermediate-experienced surgeons (>100 FB), no differences occurred between RTB and ETB. In the total cohort, at least intermediate-experienced surgeons detected significantly more sPC (10%, p = 0.008) than novices. Thus, targeted transperineal MRI/TRUS-FB with a RTB registration system showed a similar sPC detection rate to ETB in experienced surgeons but a superior sPC detection rate to ETB in the total cohort. Low-experienced surgeons seem to benefit from RTB.
format Online
Article
Text
id pubmed-8870088
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88700882022-02-25 Impact of Surgeon’s Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores Görtz, Magdalena Nyarangi-Dix, Joanne Nyaboe Pursche, Lars Schütz, Viktoria Reimold, Philipp Schwab, Constantin Stenzinger, Albrecht Sültmann, Holger Duensing, Stefan Schlemmer, Heinz-Peter Bonekamp, David Hohenfellner, Markus Radtke, Jan Philipp Cancers (Basel) Article SIMPLE SUMMARY: For the transfer of suspicious lesions in magnetic resonance imaging (MRI) to ultrasound in prostate fusion biopsy, biopsy platforms can be distinguished by rigid or elastic image registration. This study evaluates the detection rate of these different platforms for transperineal fusion-guided prostate biopsy to detect clinically significant prostate cancer under consideration of the surgeon’s learning curve. In our cohort, rigid and elastic registration systems showed a similar prostate cancer detection rate in experienced surgeons, whereas novices seem to benefit from rigid fusion. In the total cohort, targeted fusion biopsy with a rigid registration system outperformed elastic registration target biopsy with a superior significant prostate cancer detection rate, each compared to systematic saturation biopsy. Thus, rigid target biopsy aided in reducing targeting errors that result in missing MRI-visualized significant prostate cancer. These results can provide valuable decision support in selecting a biopsy fusion platform to increase the detection rate and risk stratification of prostate cancer, especially at the beginning of the surgeon’s learning curve. ABSTRACT: Multiparametric magnetic resonance imaging (mpMRI) and MRI/ultrasound fusion-targeted prostate biopsy (FB) have excellent sensitivity in detecting significant prostate cancer (sPC). FB platforms can be distinguished by rigid (RTB) or elastic image registration (ETB). We compared RTB and ETB by analyzing sPC detection rates of both RTB and ETB at different stages of the surgeons’ learning curve. Patients undergoing RTB between 2015–2017 (n = 502) were compared to patients undergoing ETB from 2017–2019 (n = 437). SPC detection rates were compared by Chi-square-test on patient-basis. Combination of transperineal systematic biopsy and each TB served as reference and sub-analyses were performed for different grades of surgeon’s experience. In the RTB subgroup, 233 men (46%) had sPC, compared to 201 (46%) in the ETB subgroup. RTB alone detected 94% of men with sPC and ETB 87% (p = 0.02). However, for at least intermediate-experienced surgeons (>100 FB), no differences occurred between RTB and ETB. In the total cohort, at least intermediate-experienced surgeons detected significantly more sPC (10%, p = 0.008) than novices. Thus, targeted transperineal MRI/TRUS-FB with a RTB registration system showed a similar sPC detection rate to ETB in experienced surgeons but a superior sPC detection rate to ETB in the total cohort. Low-experienced surgeons seem to benefit from RTB. MDPI 2022-02-10 /pmc/articles/PMC8870088/ /pubmed/35205634 http://dx.doi.org/10.3390/cancers14040886 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Görtz, Magdalena
Nyarangi-Dix, Joanne Nyaboe
Pursche, Lars
Schütz, Viktoria
Reimold, Philipp
Schwab, Constantin
Stenzinger, Albrecht
Sültmann, Holger
Duensing, Stefan
Schlemmer, Heinz-Peter
Bonekamp, David
Hohenfellner, Markus
Radtke, Jan Philipp
Impact of Surgeon’s Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores
title Impact of Surgeon’s Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores
title_full Impact of Surgeon’s Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores
title_fullStr Impact of Surgeon’s Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores
title_full_unstemmed Impact of Surgeon’s Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores
title_short Impact of Surgeon’s Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores
title_sort impact of surgeon’s experience in rigid versus elastic mri/trus-fusion biopsy to detect significant prostate cancer using targeted and systematic cores
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870088/
https://www.ncbi.nlm.nih.gov/pubmed/35205634
http://dx.doi.org/10.3390/cancers14040886
work_keys_str_mv AT gortzmagdalena impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores
AT nyarangidixjoannenyaboe impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores
AT purschelars impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores
AT schutzviktoria impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores
AT reimoldphilipp impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores
AT schwabconstantin impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores
AT stenzingeralbrecht impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores
AT sultmannholger impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores
AT duensingstefan impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores
AT schlemmerheinzpeter impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores
AT bonekampdavid impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores
AT hohenfellnermarkus impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores
AT radtkejanphilipp impactofsurgeonsexperienceinrigidversuselasticmritrusfusionbiopsytodetectsignificantprostatecancerusingtargetedandsystematiccores